Glow Lifetech Corp. (GLOW.CN)

CAD 0.07

(0.0%)

Total Debt Summary of Glow Lifetech Corp.

  • Glow Lifetech Corp.'s latest annual total debt in 2023 was 116.18 Thousand CAD , down -81.88% from previous year.
  • Glow Lifetech Corp.'s latest quarterly total debt in 2024 Q2 was 359.51 Thousand CAD , down -13.02% from previous quarter.
  • Glow Lifetech Corp. reported annual total debt of 641.14 Thousand CAD in 2022, up 1505.66% from previous year.
  • Glow Lifetech Corp. reported annual total debt of 39.93 Thousand CAD in 2021, up 523.91% from previous year.
  • Glow Lifetech Corp. reported quarterly total debt of 359.51 Thousand CAD for 2024 Q2, down -13.02% from previous quarter.
  • Glow Lifetech Corp. reported quarterly total debt of 955.11 Thousand CAD for 2023 Q2, up 40.88% from previous quarter.

Annual Total Debt Chart of Glow Lifetech Corp. (2023 - 2019)

Historical Annual Total Debt of Glow Lifetech Corp. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 116.18 Thousand CAD -81.88%
2022 641.14 Thousand CAD 1505.66%
2021 39.93 Thousand CAD 523.91%
2020 6400.00 CAD 0.0%
2019 6400.00 CAD 0.0%

Peer Total Debt Comparison of Glow Lifetech Corp.

Name Total Debt Total Debt Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 20 Thousand CAD -480.92%
BetterLife Pharma Inc. 245.23 Thousand CAD 52.623%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. 3.87 Million CAD 97.002%
Rapid Dose Therapeutics Corp. 2.45 Million CAD 95.265%
Defence Therapeutics Inc. 1.74 Million CAD 93.347%
Entheon Biomedical Corp. - CAD -Infinity%
Gemina Laboratories Ltd. 285.32 Thousand CAD 59.28%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. 253.53 Thousand CAD 54.175%
Doseology Sciences Inc. - CAD -Infinity%
MYND Life Sciences Inc. 3 Million CAD 96.127%
Nova Mentis Life Science Corp. - CAD -Infinity%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. 3.83 Million CAD 96.97%
Telescope Innovations Corp. - CAD -Infinity%